Virus, Vector and Cell Culture Core
病毒、载体和细胞培养核心
基本信息
- 批准号:10714178
- 负责人:
- 金额:$ 30.95万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-01 至 2028-08-31
- 项目状态:未结题
- 来源:
- 关键词:3-DimensionalAdherent CultureAwardBiologicalCell Culture TechniquesCellsClustered Regularly Interspaced Short Palindromic RepeatsComplementary DNAConsultationsConsumptionDatabasesDermalEngineeringGenerationsGenesGenetic RecombinationGenetic TranscriptionGoalsGuide RNAHerpesviridaeHuman Herpesvirus 4Human Herpesvirus 8HypoxiaIn VitroIndividualInfectionKnock-outLaboratoriesLentivirusMethodsMolecularMutagenesisMutationOncogenic VirusesOnline SystemsOrganoidsPreparationPrimary Cell CulturesProceduresProductionProductivityProteinsReagentRecombinantsReproducibilityResearch ActivityResearch PersonnelResourcesServicesSiteStandardizationSystemTimeTransfectionViralVirusconditional knockoutcostdesignexperimental studyexpression vectorkeratinocyteknock-downlarge scale productionmedical schoolsmemberoperationoral cavity epitheliumprogramsrecombinant virusrepositorysmall hairpin RNAthree dimensional cell culturevector
项目摘要
Abstract
Core B: Virus Vector and Cell Culture Core
The Virus Vector and Cell Culture Core (VVCCC) will be responsible for 1) recombinant virus design
consultation, 2) vector and viral reagent repository; 3) generation of site-directed mutations in EBV and KSHV
bacmids, 4) large scale production of recombinant and wild-type EBV, KSHV and MCPyV, 5) organoid culture
establishment, 6) infections of organoids with viruses, 7) amplification of primary cultures in vitro post-infection,
and 8) generation of gRNA lentiviral constructs for CRISPR knock out of specific genes. These goals will be
accomplished through a centralized laboratory approach which provides a set of standardized services,
including state of the art methods in herpes virus molecular engineering and recombination-based
mutagenesis (i.e. Kan-SacB, Kan-rpsL, Gal-K, and LoxP-Kan for conditional knock-outs), production of
recombinant Lentivirus expression vectors for cDNA, gRNA and shRNA, and production of EBV and KSHV
from stably transfected HEK-293 cells (recombinant viruses), GFP tagged viruses with specific mutations, or
BCBL1 and LCL1 cells (wild-type viruses), primary and established organoid 3D cultures. Since it is expected
that this program project will generate unique resources for research, the core will be responsible for storage of
recombinant viruses, bacmids, reagents for recombineering and Lenti-virus production, as well as
management of adequate databases that users can access and search via a web-based browser. Expertise in
all aspects of protein and virus production, as well as primary and 3D culture systems will be provided to all
four projects for the lifetime of the program award.
摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ERLE S. ROBERTSON其他文献
ERLE S. ROBERTSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ERLE S. ROBERTSON', 18)}}的其他基金
Botswana-UPenn: Research Consortium of HPV-Related Cervical Cancer in HIV Patient
博茨瓦纳-宾夕法尼亚大学:HIV 患者 HPV 相关宫颈癌研究联盟
- 批准号:
10834480 - 财政年份:2023
- 资助金额:
$ 30.95万 - 项目类别:
Project 1: KSHV reprograms replication and metabolic activities in hypoxia
项目 1:KSHV 在缺氧条件下重新编程复制和代谢活动
- 批准号:
10714173 - 财政年份:2023
- 资助金额:
$ 30.95万 - 项目类别:
Transcription and Replication of Oncogenic Viruses in Hypoxia
缺氧条件下致癌病毒的转录和复制
- 批准号:
10714172 - 财政年份:2023
- 资助金额:
$ 30.95万 - 项目类别:
Project 2: KSHV induces tumorigenesis by harnessing differentiation in hypoxia
项目2:KSHV利用缺氧条件下的分化诱导肿瘤发生
- 批准号:
10714174 - 财政年份:2023
- 资助金额:
$ 30.95万 - 项目类别:
Tumor suppressor reprogramming by EBV through post-translational modification
EBV 通过翻译后修饰重编程肿瘤抑制因子
- 批准号:
10402055 - 财政年份:2022
- 资助金额:
$ 30.95万 - 项目类别:
Tumor suppressor reprogramming by EBV through post-translational modification
EBV 通过翻译后修饰重编程肿瘤抑制因子
- 批准号:
10684650 - 财政年份:2022
- 资助金额:
$ 30.95万 - 项目类别:
Epigenetic Regulation of KSHV Genome Replication
KSHV 基因组复制的表观遗传调控
- 批准号:
10457380 - 财政年份:2019
- 资助金额:
$ 30.95万 - 项目类别:
Epigenetic Regulation of KSHV Genome Replication
KSHV 基因组复制的表观遗传调控
- 批准号:
9978759 - 财政年份:2019
- 资助金额:
$ 30.95万 - 项目类别:
相似海外基金
Probe-type nanowire sensor for label-free, in-situ, ultrasensitive detection of biomarkers from single cell in adherent culture
探针型纳米线传感器,用于无标记、原位、超灵敏地检测贴壁培养中单细胞的生物标志物
- 批准号:
21K14653 - 财政年份:2021
- 资助金额:
$ 30.95万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
CAREER: Rolled Scaffold for High-Density Adherent Culture of Mammalian Cells
职业:用于哺乳动物细胞高密度贴壁培养的滚动支架
- 批准号:
1848251 - 财政年份:2019
- 资助金额:
$ 30.95万 - 项目类别:
Continuing Grant